NOV 22, 2019 10:53 AM PST

Federal Government Weighs in on Marijuana and Opioid Addiction

WRITTEN BY: C Reardon

The U.S. government is weighing in on the hot topic of whether or not medical marijuana is a successful tool in treating opioid addiction by barring the use of federal dollars, allotted for opioid addiction treatment, on medical marijuana.  

The federal agency that gives out money to states for treatment programs believes that there is not enough evidence to suggest that money for opioid addiction should be used on marijuana as a tool or treatment in this area. "We felt that it was time to make it clear that we did not want individuals receiving funds for treatment services to be exposed to marijuana and somehow given the impression that it's a treatment," Dr. Elinore McCance-Katz, an employee at this federal agency, told the Washington Post

Photo Source: pexels.com

Federal officials are firm that federal grant money given out by the federal Substance Abuse and Mental Health Services Administration will not be used to buy marijuana, and that chosen programs will not permit the use of marijuana for treatment in both opioid addiction and mental health disorders. 

This does not apply to federal funding and grants allotted for medical marijuana research. 

Addiction treatment programs are being asked to keep documentation as proof that they are encouraging patients to stop the use of marijuana as a treatment for both addiction and mental health disorders. If they do not comply, the programs are at risk of losing the federal money, McCance-Katz confirms. 

Photo Source: pexels.com

States can decide what disorders they add to their medical marijuana lists, adding ailments like chronic pain and multiple sclerosis, to which there is substantial scientific evidence attached. The U.S. government is arguing that research used to prove marijuana is effective in aiding opioid addiction is based on anecdotal reports and surveys that do not determine cause and effect. 

 

About the Author
  • Chelsey is a content strategist and copywriter with a business degree. She has a background in public relations and marketing and enjoys writing about various topics, from health, to lifestyle, to women’s issues. Since 2016, she has written for a variety of online publications, earning well over 100,000 shares. She published her first book in 2019.
You May Also Like
JUL 11, 2020
Genetics & Genomics
Cocaine Changes Gene Expression in a Specific Part of the Brain
JUL 11, 2020
Cocaine Changes Gene Expression in a Specific Part of the Brain
Scientists have begun to examine how cocaine exposure alters gene expression in a specific region of the brain, and the ...
JUL 13, 2020
Cannabis Sciences
Cannabis Briefly Alleviates PTSD Symptoms
JUL 13, 2020
Cannabis Briefly Alleviates PTSD Symptoms
Therapy is the primary recommended treatment for individuals with post-traumatic stress disorder (PTSD), but a new study ...
JUL 16, 2020
Cell & Molecular Biology
Newly Discovered Cell Type Predicts Arthritis Flares
JUL 16, 2020
Newly Discovered Cell Type Predicts Arthritis Flares
Arthritis can be a very unpredictable disease, causing challenges for those that have it by suddenly flaring up and maki ...
JUL 26, 2020
Genetics & Genomics
MAIT Cell Disappearance is Connected to a Genetic Mutation
JUL 26, 2020
MAIT Cell Disappearance is Connected to a Genetic Mutation
Mucosal-associated invariant T cells appear to be a critical part of the human immune system, and dysfunction in these c ...
AUG 04, 2020
Microbiology
Johns Hopkins is Starting COVID-19 Plasma Trials
AUG 04, 2020
Johns Hopkins is Starting COVID-19 Plasma Trials
Researchers at JHU are starting a controlled trial that aims to learn whether plasma from recovered COVID-19 patients ca ...
AUG 09, 2020
Microbiology
Could Huntington's Disease be Treated Using Gut Bacteria?
AUG 09, 2020
Could Huntington's Disease be Treated Using Gut Bacteria?
The gut microbiome, the community of microbes that helps us digest food and absorb nutrients, has been shown to have an ...
Loading Comments...